[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Deep Brain Stimulation in Parkinson's Disease Market 2023 by Company, Regions, Type and Application, Forecast to 2029

February 2023 | 89 pages | ID: GF226BB6D091EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some of the symptoms of Parkinson's Disease that cannot be adequately controlled with medications. It is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.

According to our (Global Info Research) latest study, the global Deep Brain Stimulation in Parkinson's Disease market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Deep Brain Stimulation in Parkinson's Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Deep Brain Stimulation in Parkinson's Disease market size and forecasts, in consumption value ($ Million), 2018-2029

Global Deep Brain Stimulation in Parkinson's Disease market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Deep Brain Stimulation in Parkinson's Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Deep Brain Stimulation in Parkinson's Disease market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Deep Brain Stimulation in Parkinson's Disease

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Deep Brain Stimulation in Parkinson's Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Aleva Neurotherapeutics SA, Beijing PINS Medical Co, Boston Scientific Corporation and Functional Neuromodulation Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Deep Brain Stimulation in Parkinson's Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Dual Channel Deep brain Stimulator
  • Single Channel Deep brain Stimulator
Market segment by Application
  • Hospitals
  • Neurology Clinics
  • Research Centers
Market segment by players, this report covers
  • Abbott
  • Aleva Neurotherapeutics SA
  • Beijing PINS Medical Co
  • Boston Scientific Corporation
  • Functional Neuromodulation Ltd
  • Medtronic
  • Neuronetics Inc.
  • NeuroPace Inc.
  • Nevro Corporation
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Deep Brain Stimulation in Parkinson's Disease product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Deep Brain Stimulation in Parkinson's Disease, with revenue, gross margin and global market share of Deep Brain Stimulation in Parkinson's Disease from 2018 to 2023.

Chapter 3, the Deep Brain Stimulation in Parkinson's Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Deep Brain Stimulation in Parkinson's Disease market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Deep Brain Stimulation in Parkinson's Disease.

Chapter 13, to describe Deep Brain Stimulation in Parkinson's Disease research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Deep Brain Stimulation in Parkinson's Disease
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Deep Brain Stimulation in Parkinson's Disease by Type
  1.3.1 Overview: Global Deep Brain Stimulation in Parkinson's Disease Market Size by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Type in 2022
  1.3.3 Dual Channel Deep brain Stimulator
  1.3.4 Single Channel Deep brain Stimulator
1.4 Global Deep Brain Stimulation in Parkinson's Disease Market by Application
  1.4.1 Overview: Global Deep Brain Stimulation in Parkinson's Disease Market Size by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Hospitals
  1.4.3 Neurology Clinics
  1.4.4 Research Centers
1.5 Global Deep Brain Stimulation in Parkinson's Disease Market Size & Forecast
1.6 Global Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast by Region
  1.6.1 Global Deep Brain Stimulation in Parkinson's Disease Market Size by Region: 2018 VS 2022 VS 2029
  1.6.2 Global Deep Brain Stimulation in Parkinson's Disease Market Size by Region, (2018-2029)
  1.6.3 North America Deep Brain Stimulation in Parkinson's Disease Market Size and Prospect (2018-2029)
  1.6.4 Europe Deep Brain Stimulation in Parkinson's Disease Market Size and Prospect (2018-2029)
  1.6.5 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size and Prospect (2018-2029)
  1.6.6 South America Deep Brain Stimulation in Parkinson's Disease Market Size and Prospect (2018-2029)
  1.6.7 Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Market Size and Prospect (2018-2029)

2 COMPANY PROFILES

2.1 Abbott
  2.1.1 Abbott Details
  2.1.2 Abbott Major Business
  2.1.3 Abbott Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.1.4 Abbott Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Abbott Recent Developments and Future Plans
2.2 Aleva Neurotherapeutics SA
  2.2.1 Aleva Neurotherapeutics SA Details
  2.2.2 Aleva Neurotherapeutics SA Major Business
  2.2.3 Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.2.4 Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Aleva Neurotherapeutics SA Recent Developments and Future Plans
2.3 Beijing PINS Medical Co
  2.3.1 Beijing PINS Medical Co Details
  2.3.2 Beijing PINS Medical Co Major Business
  2.3.3 Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.3.4 Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Beijing PINS Medical Co Recent Developments and Future Plans
2.4 Boston Scientific Corporation
  2.4.1 Boston Scientific Corporation Details
  2.4.2 Boston Scientific Corporation Major Business
  2.4.3 Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.4.4 Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Boston Scientific Corporation Recent Developments and Future Plans
2.5 Functional Neuromodulation Ltd
  2.5.1 Functional Neuromodulation Ltd Details
  2.5.2 Functional Neuromodulation Ltd Major Business
  2.5.3 Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.5.4 Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Functional Neuromodulation Ltd Recent Developments and Future Plans
2.6 Medtronic
  2.6.1 Medtronic Details
  2.6.2 Medtronic Major Business
  2.6.3 Medtronic Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.6.4 Medtronic Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Medtronic Recent Developments and Future Plans
2.7 Neuronetics Inc.
  2.7.1 Neuronetics Inc. Details
  2.7.2 Neuronetics Inc. Major Business
  2.7.3 Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.7.4 Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Neuronetics Inc. Recent Developments and Future Plans
2.8 NeuroPace Inc.
  2.8.1 NeuroPace Inc. Details
  2.8.2 NeuroPace Inc. Major Business
  2.8.3 NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.8.4 NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 NeuroPace Inc. Recent Developments and Future Plans
2.9 Nevro Corporation
  2.9.1 Nevro Corporation Details
  2.9.2 Nevro Corporation Major Business
  2.9.3 Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Product and Solutions
  2.9.4 Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Nevro Corporation Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Deep Brain Stimulation in Parkinson's Disease Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
  3.2.1 Market Share of Deep Brain Stimulation in Parkinson's Disease by Company Revenue
  3.2.2 Top 3 Deep Brain Stimulation in Parkinson's Disease Players Market Share in 2022
  3.2.3 Top 6 Deep Brain Stimulation in Parkinson's Disease Players Market Share in 2022
3.3 Deep Brain Stimulation in Parkinson's Disease Market: Overall Company Footprint Analysis
  3.3.1 Deep Brain Stimulation in Parkinson's Disease Market: Region Footprint
  3.3.2 Deep Brain Stimulation in Parkinson's Disease Market: Company Product Type Footprint
  3.3.3 Deep Brain Stimulation in Parkinson's Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Deep Brain Stimulation in Parkinson's Disease Consumption Value and Market Share by Type (2018-2023)
4.2 Global Deep Brain Stimulation in Parkinson's Disease Market Forecast by Type (2024-2029)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Application (2018-2023)
5.2 Global Deep Brain Stimulation in Parkinson's Disease Market Forecast by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2029)
6.2 North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2029)
6.3 North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country
  6.3.1 North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2029)
  6.3.2 United States Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  6.3.3 Canada Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  6.3.4 Mexico Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)

7 EUROPE

7.1 Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2029)
7.2 Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2029)
7.3 Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country
  7.3.1 Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2029)
  7.3.2 Germany Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  7.3.3 France Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  7.3.4 United Kingdom Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  7.3.5 Russia Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  7.3.6 Italy Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)

8 ASIA-PACIFIC

8.1 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region
  8.3.1 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Region (2018-2029)
  8.3.2 China Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  8.3.3 Japan Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  8.3.4 South Korea Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  8.3.5 India Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  8.3.6 Southeast Asia Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  8.3.7 Australia Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)

9 SOUTH AMERICA

9.1 South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2029)
9.2 South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2029)
9.3 South America Deep Brain Stimulation in Parkinson's Disease Market Size by Country
  9.3.1 South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2029)
  9.3.2 Brazil Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  9.3.3 Argentina Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country
  10.3.1 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2029)
  10.3.2 Turkey Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  10.3.3 Saudi Arabia Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)
  10.3.4 UAE Deep Brain Stimulation in Parkinson's Disease Market Size and Forecast (2018-2029)

11 MARKET DYNAMICS

11.1 Deep Brain Stimulation in Parkinson's Disease Market Drivers
11.2 Deep Brain Stimulation in Parkinson's Disease Market Restraints
11.3 Deep Brain Stimulation in Parkinson's Disease Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
  11.5.1 Influence of COVID-19
  11.5.2 Influence of Russia-Ukraine War

12 INDUSTRY CHAIN ANALYSIS

12.1 Deep Brain Stimulation in Parkinson's Disease Industry Chain
12.2 Deep Brain Stimulation in Parkinson's Disease Upstream Analysis
12.3 Deep Brain Stimulation in Parkinson's Disease Midstream Analysis
12.4 Deep Brain Stimulation in Parkinson's Disease Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 8. Abbott Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Aleva Neurotherapeutics SA Company Information, Head Office, and Major Competitors
Table 11. Aleva Neurotherapeutics SA Major Business
Table 12. Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 13. Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Aleva Neurotherapeutics SA Recent Developments and Future Plans
Table 15. Beijing PINS Medical Co Company Information, Head Office, and Major Competitors
Table 16. Beijing PINS Medical Co Major Business
Table 17. Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 18. Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Beijing PINS Medical Co Recent Developments and Future Plans
Table 20. Boston Scientific Corporation Company Information, Head Office, and Major Competitors
Table 21. Boston Scientific Corporation Major Business
Table 22. Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 23. Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Boston Scientific Corporation Recent Developments and Future Plans
Table 25. Functional Neuromodulation Ltd Company Information, Head Office, and Major Competitors
Table 26. Functional Neuromodulation Ltd Major Business
Table 27. Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 28. Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Functional Neuromodulation Ltd Recent Developments and Future Plans
Table 30. Medtronic Company Information, Head Office, and Major Competitors
Table 31. Medtronic Major Business
Table 32. Medtronic Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 33. Medtronic Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Medtronic Recent Developments and Future Plans
Table 35. Neuronetics Inc. Company Information, Head Office, and Major Competitors
Table 36. Neuronetics Inc. Major Business
Table 37. Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 38. Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Neuronetics Inc. Recent Developments and Future Plans
Table 40. NeuroPace Inc. Company Information, Head Office, and Major Competitors
Table 41. NeuroPace Inc. Major Business
Table 42. NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 43. NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. NeuroPace Inc. Recent Developments and Future Plans
Table 45. Nevro Corporation Company Information, Head Office, and Major Competitors
Table 46. Nevro Corporation Major Business
Table 47. Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Product and Solutions
Table 48. Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nevro Corporation Recent Developments and Future Plans
Table 50. Global Deep Brain Stimulation in Parkinson's Disease Revenue (USD Million) by Players (2018-2023)
Table 51. Global Deep Brain Stimulation in Parkinson's Disease Revenue Share by Players (2018-2023)
Table 52. Breakdown of Deep Brain Stimulation in Parkinson's Disease by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Deep Brain Stimulation in Parkinson's Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Deep Brain Stimulation in Parkinson's Disease Players
Table 55. Deep Brain Stimulation in Parkinson's Disease Market: Company Product Type Footprint
Table 56. Deep Brain Stimulation in Parkinson's Disease Market: Company Product Application Footprint
Table 57. Deep Brain Stimulation in Parkinson's Disease New Market Entrants and Barriers to Market Entry
Table 58. Deep Brain Stimulation in Parkinson's Disease Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Share by Type (2018-2023)
Table 61. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Forecast by Type (2024-2029)
Table 62. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2023)
Table 63. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Forecast by Application (2024-2029)
Table 64. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Deep Brain Stimulation in Parkinson's Disease Raw Material
Table 95. Key Suppliers of Deep Brain Stimulation in Parkinson's Disease Raw Materials

LIST OF FIGURES

Figure 1. Deep Brain Stimulation in Parkinson's Disease Picture
Figure 2. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Type in 2022
Figure 4. Dual Channel Deep brain Stimulator
Figure 5. Single Channel Deep brain Stimulator
Figure 6. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Picture
Figure 9. Neurology Clinics Picture
Figure 10. Research Centers Picture
Figure 11. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Deep Brain Stimulation in Parkinson's Disease Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Region in 2022
Figure 16. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Deep Brain Stimulation in Parkinson's Disease Revenue Share by Players in 2022
Figure 22. Deep Brain Stimulation in Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Deep Brain Stimulation in Parkinson's Disease Market Share in 2022
Figure 24. Global Top 6 Players Deep Brain Stimulation in Parkinson's Disease Market Share in 2022
Figure 25. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Share by Type (2018-2023)
Figure 26. Global Deep Brain Stimulation in Parkinson's Disease Market Share Forecast by Type (2024-2029)
Figure 27. Global Deep Brain Stimulation in Parkinson's Disease Consumption Value Share by Application (2018-2023)
Figure 28. Global Deep Brain Stimulation in Parkinson's Disease Market Share Forecast by Application (2024-2029)
Figure 29. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 39. France Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Region (2018-2029)
Figure 46. China Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 49. India Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Deep Brain Stimulation in Parkinson's Disease Consumption Value (2018-2029) & (USD Million)
Figure 63. Deep Brain Stimulation in Parkinson's Disease Market Drivers
Figure 64. Deep Brain Stimulation in Parkinson's Disease Market Restraints
Figure 65. Deep Brain Stimulation in Parkinson's Disease Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Deep Brain Stimulation in Parkinson's Disease in 2022
Figure 68. Manufacturing Process Analysis of Deep Brain Stimulation in Parkinson's Disease
Figure 69. Deep Brain Stimulation in Parkinson's Disease Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source


More Publications